Navigation Links
An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market
Date:6/23/2009

Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources

WALTHAM, Mass., June 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a 28 percent increase in the diagnosed prevalent population will drive growth in the chronic obstructive pulmonary disease (COPD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Despite market constraints that include currently low diagnosis rates, pricing and reimbursement restrictions and challenging regulatory landscapes, the COPD drug market will grow by nearly $4.3 billion from 2008 to 2018.

The new Pharmacor report entitled Chronic Obstructive Pulmonary Disease finds that maintenance therapies dominated the COPD market in 2008 as nearly 80 percent of COPD sales were generated by such agents. Although safety concerns are associated with several maintenance therapies commonly prescribed for COPD, including ICS-containing products as well as inhaled anticholinergics, physicians indicate that they will continue to widely prescribe these drugs to their COPD patients but will remain vigilant in monitoring the safety of these drugs in their patients who receive them. The report finds that as new long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combinations, long-acting muscarinic antagonists (LAMAs), and LABA/LAMA products emerge from clinical development over the next decade, the use of maintenance therapies will continue to increase.

Several once-daily dosed LABAs such as Novartis's indacaterol, Boehringer Ingelheim's BI-1744-CL and GlaxoSmithKline/Theravance's GW-642444 will also enter the COPD market over the next decade. The report finds that these emerging once-daily LABAs will be the cornerstones of combination product development programs which will result in new LABA/ICSs and LABA/LAMAs, the latter being a new and promising class of combination drugs. While all of these agents will achieve their greatest potential as components of combination products, drug marketers are expected to position these agents as add-on therapy to LAMA treatment and/or as monotherapies for first-line use in patients with moderate COPD in order to maximize the commercial potential of these molecules.

"While Advair and Spiriva dominated the COPD market in 2008, we expect their share of the COPD market to decrease through 2018," said Decision Resources Analyst Regina Jammen, M.Sc. "As new maintenance therapies and non-innovator versions of several market-leading branded products launch, the COPD market will shift from a few key products to numerous therapies with subsequently less market concentration on only a few brands. However, even with these changes to the market landscape, the unmet need remains for drugs that can dramatically reduce exacerbation rates and/or slow or halt the progression of COPD."

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources                      Decision Resources, Inc.
    Christopher Comfort                     Elizabeth Marshall
    781-296-2597                            781-296-2563
    ccomfort@dresources.com                 emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U.S. Army Increases Medical and Dental School Benefits
2. A 50% Increase in Medical Bankruptcies - A Worry for Adults Assisting Aging Parents
3. Winner Medical to Benefit From the Increase of Tax Rebate Rate for Exports From China
4. Hodgkin lymphoma survivors have increased risk of stroke and transient ischemic attack
5. No Matter the Vehicle, Sending Text Messages While Driving Increases Risk of Accidents, Warns New York Auto Accident Lawyer
6. Hartford grants increase support for geriatric social work training
7. Study Shows Increases in Working After 65 and Using Commercial Insurance
8. Depression may increase Alzheimers risk in people with memory problems
9. Despite Generic Erosion of Key Brands, the Hospital-Acquired Gram Negative Infections Drug Market Will Increase by $1 Billion from 2008 to 2018
10. Colonoscopy Risks Increase With Age and Illness
11. For Men Over 50, Odds of Eye Discomfort Increases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a ... and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is ... to some of the world’s leading providers of cereal and other breakfast foods. Its ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Revolutionary technology includes multi-speaker listening to ... leaders in advanced audiology and hearing aid technology, has ... the world,s first internet connected hearing aid that opens ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... firsts,: , TwinLink™ - the first dual ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: